NCT06431477

Efficacy and Safety of Telmisartan Compared With Losartan

A Multi-center, Randomized, Open-label, Active Comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared With Losartan in Patients With Diabetic Nephropathy and Hypertension

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 98 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension

Detailed description

A Multi-center, Randomized, Open-label, Active comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared with Losartan in Patients with Diabetic Nephropathy and Hypertension

Conditions

• Diabetic Nephropathies
• Hypertension

Interventions

Type	Name	Description
DRUG	telmisartan	QD, PO
DRUG	Losartan	QD, PO

Timeline

• Start date: 2023-04-19
• Primary completion: 2025-10-31
• Completion: 2025-10-31
• First posted: 2024-05-28
• Last updated: 2024-05-28

Locations

1 site across 1 country: South Korea